DRUGS CONTROL ADMINISTRATION

GOVERNMENT OF TELANGANA
  • Home
  • Contact Us
  • Dept Login
  • Home
  • About Us
  • Services
  • Key Contacts
    • Hon'ble Minister
    • State Officers
    • Regional Officers
    • District Officers
    • Drugs Inspectors
  • Circulars & GOs
    • Circulars
    • GOs
  • Related Links
  • Gallery
  • Citizen Charter
  • Act & Rules
  • RTI Act
  • How To Apply
    1. Circular Memo for ensuring the use of authentic Indian Pharmacopoeia, IP Reference Standards IPRS and impurity standards for quality testing of drugs.
    2. Circular issued regarding certain instructions on sale of Oxytocin
    3. DCA - Circular on Risk-based Sampling
    4. DCA - Advisory Procurement and testing of the raw materials Glycerin and Propylene Glycol by the Cough Syrup manufacturers
    5. Classification of Medical Devices - List of Medical Devices, IVDs along with their risk class under provisions of sub-rule 1 Rule 4 of the Medical Devices Rules, 2017
    6. Medical Devices Rules 2017
    7. List of Notified Bodies registered with CDSCO under Medical Devices Rules.
    8. Grouping guidelines for Medical Devices applications
    9. FAQs on Medical Devices Rules
    10. Notice regarding List of Reference Products for conduct of BE Study for Oral Solid Dosage Forms containing BCS Class II and Class IV drugs
    11. Fixed Dose Combinations FDCs approved by DCG (I) since 1961 to 31st December 2019
    12. Prohibition of certain FDCs appeared in the list of 294 FDCs, under Section 26A
    13. GUIDELINES FOR TAKING ACTION ON SAMPLES OF DRUGS DECLARED SPURIOUS OR NOT OF STANDARD QUALITY
    14. Standards for Blood Banks and Blood Transfusion Services
    15. Guideline issued by CDSCO for uploading manufacturing sites and formulation data on the SUGAM Portal by manufacturers
    16. Procedure for submission of cough syrups to be exported by manufacturer, exporter directly to Central, NABL accredited state testing laboratories for testing purpose.
    17. Instructions issued to Drugs Inspectors regarding regulation of sale and distribution of N95 Masks, PPE, Hand Sanitizers and related medicines.
    18. Guidance Document and Steps to be followed by the manufcaturers/importers for registration of Non-notified Medical Devices.
    19. Cosmetics Rules 2020
    20. Implementation of regulation of pre shipment document verification, physical inspection, QC testing, issuance of CRIA for pharmaceuticals to be exported to The Gambia by Medicines Control Agency
    21. Circular issued regarding strict enforcement of testing of Aluminum in Purified Water, raw materials used for preparation of Dialysis Solutions and in the final product Haemodialysis Solutions.
    22. Circular regarding procedure to be adopted in the investigation and recall of the drugs declared as NSQ or Spurious
    23. Circular regarding Rule 84AB for uploading data of drug manufacturing facilities and approved drug formulations on SUGAM portal
    24. Circular of DCGI regarding modalities of Joint Inspection for Grant of Manufacturing Licence
    25. GSR 1337E dated 27-10-2017 regarding retention of licences, omission of renewal
    26. Consequential Amendments to GSR 1337E Gazette Notification
    27. New Drugs and Clinical Trial Rules 2019
    28. FAQs on New Drugs and Clinical Trial Rules 2019

Main Menu

  • Objectives of DCA
  • Organisational Setup
  • Client's Charter
  • Statute Implemented
  • Performance of DCA

Public Services

  • Online Drugs Licensing System
  • DCG(I) Approved Drugs
  • Blood Banks
  • Banned Drugs
  • NSQ Drugs
  • Medical Stores
  • Manufacturing Units
  • Medical shops in Govt Hospitals
  • Consumer Awareness
  Your are Visitor #441475

Designed, Developed and Hosted by National Informatics Centre, Hyderabad.

Content owned, maintained and updated by Department of Drugs Control Administration, Government of Telangana